All News

In a Pharmacy Times® Continuing Education Supplement, Leslie J. Vaughan, BS, RPH, examined cost and health care utilization in patients using immunoglobulin agents.

To date, the FDA has granted rivaroxaban 8 indications, 6 of which are specifically for the treatment, prevention, and reduction in the risk of recurrence of venous thromboemolism across a wide range of patient populations.

A researcher at the Washington University School of Medicine in St.Louis has received close to $7.5 million in total funding for research towards development of stem cell-based treatments for chronic pulmonary disease (COPD), asthma, and other disorders.

A study by the CDC has found that only approximately half of pregnant women reported receiving the influenza, and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines.

Although 62% of the first professional degrees in pharmacy were awarded to women in 2017-2018,1 there are only about half as many female pharmacy owners as there are women graduating from pharmacy school.

Lasmiditan (Reyvow, Eli Lilly) resolved pain and most bothersome symptoms within 2 hours of treatment in patients with migraine.

Top news of the week from Specialty Pharmacy Times.

“Sesame Street” has joined the fight against opioid addiction by creating a storyine to help educate children about the opioid epidemic and how it affects families.

This article is the third in a series on difficult to pronounce drug names.

Officials from the FDA have allowed marketing of a rapid diagnostic test (RDT) to help detect Ebola virus antigens in the bloodstream from certain living individuals and samples from recently deceased individuals suspected to have Ebola.

Top news of the day from across the health care landscape.

A phase 3 study assessed the efficacy and safety of plitidepsin (Aplidin) in combination with dexamethasone in patients with relapsed/refractory multiple myeloma.

The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.

Top news of the day from across the health care landscape.

Long-term treatment with dupilumab showed benefit in adolescents with atopic dermatitis comparable with the treatment’s effect in adults.

A recent study has revealed that just under half of the US population fears random mass shootings and terrorist attacks.

The grants were awarded through the Orphan Products Clinical Trials Grants Program, which is funded by Congress.

The Pacific Ketamine Institute is now offering esketamine nasal spray (Spravato, Johnson & Johnson) for the treatment of patients who don't respond well to traditional oral antidepressants. It is a prescription medication to be used alongside an oral antidepressant.1